Delivery Order SPE2DB25D9321-SPE2DB25FQWMC

Award Date 2/12/25
Potential Completion Date 3/6/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $11,006.95 contract is for the supply of LENVIMA 20 MG DAILY DOSE 60S, a pharmaceutical product, with a period of performance through January 3, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of LENVIMA 20 MG DAILY DOSE 60S, with a ceiling value of $11,006.95 and a period of performance through July 2, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which runs...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $14,261.09 award is for the delivery of LENVIMA 10 MG DAILY DOSE 30S, a prescription medication. The order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which allows the DLA to issue delivery orders for a comprehensive...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $14,261.09, is for the supply of LENVIMA 10 MG DAILY DOSE 30S, a pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $10,662.16 award is for the procurement of LENVIMA 14 MG DAILY DOSE 60S, a specialized pharmaceutical product. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 single-award Indefinite Delivery Contract (IDC) with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,006.95 order is for LENVIMA 10 MG DAILY DOSE 30S and has a completion date of June 11, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA valued at up to $499,999,999, which allows the agency to place orders for a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,006.95 contract is for the supply of LENVIMA 8 MG DAILY DOSE 60S, a specialized pharmaceutical product. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This IDC enables the DLA to...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $14,261.09, is for the supply of LENVIMA 10 MG DAILY DOSE 30S, a pharmaceutical product. The contract has a completion date of February 7, 2022 and was awarded on January 14, 2022. DMS Pharmaceutical Group Inc. is an established federal contractor that specializes in providing a wide range of...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,006.95, is for the delivery of LENVIMA 20 MG DAILY DOSE 60S, a specialized pharmaceutical product. The contract has a completion date of February 14, 2025 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a significant...
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The $10,662.16 contract is for the delivery of Lenvima 12 mg daily dose 90s, a prescription medication, to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical...
  • SPE2DB25D9321
    Indefinite Delivery Contract
  • SPE2DB25D9321-SPE2DB25FQWMC
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $11,006.95 contract is for the supply of LENVIMA 8 MG DAILY DOSE 60S, a specialized pharmaceutical product, with a performance period through March 6, 2025.

DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. This delivery order is not associated with any set-aside designation.

Generated 5/14/25, 9:55 AM